These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34027244)

  • 21. In vitro to in vivo extrapolation of effective dosimetry in developmental toxicity testing: Application of a generic PBK modelling approach.
    Fragki S; Piersma AH; Rorije E; Zeilmaker MJ
    Toxicol Appl Pharmacol; 2017 Oct; 332():109-120. PubMed ID: 28760446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
    Moxon TE; Li H; Lee MY; Piechota P; Nicol B; Pickles J; Pendlington R; Sorrell I; Baltazar MT
    Toxicol In Vitro; 2020 Mar; 63():104746. PubMed ID: 31837441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals.
    Wang J; Nolte TM; Owen SF; Beaudouin R; Hendriks AJ; Ragas AMJ
    Environ Sci Technol; 2022 May; 56(10):6500-6510. PubMed ID: 35472258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I.
    Abdullah R; Alhusainy W; Woutersen J; Rietjens IM; Punt A
    Food Chem Toxicol; 2016 Jun; 92():104-16. PubMed ID: 27016491
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Algharably EA; Di Consiglio E; Testai E; Pistollato F; Mielke H; Gundert-Remy U
    Front Toxicol; 2022; 4():885843. PubMed ID: 35924078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of in vitro experimental variation in kinetic parameters on physiologically based kinetic (PBK) model simulations.
    Punt A; Bos P; Hakkert B; Louisse J
    ALTEX; 2023; 40(2):237–247. PubMed ID: 35901496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next generation risk assessment (NGRA): Bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - A case study of doxorubicin with dose metrics considerations.
    Li H; Yuan H; Middleton A; Li J; Nicol B; Carmichael P; Guo J; Peng S; Zhang Q
    Toxicol In Vitro; 2021 Aug; 74():105171. PubMed ID: 33848589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open source physiologically based kinetic model for the chicken (Gallus gallus domesticus): Calibration and validation for the prediction residues in tissues and eggs.
    Lautz LS; Nebbia C; Hoeks S; Oldenkamp R; Hendriks AJ; Ragas AMJ; Dorne JLCM
    Environ Int; 2020 Mar; 136():105488. PubMed ID: 31991240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational models for the assessment of manufactured nanomaterials: Development of model reporting standards and mapping of the model landscape.
    Lamon L; Asturiol D; Vilchez A; Ruperez-Illescas R; Cabellos J; Richarz A; Worth A
    Comput Toxicol; 2019 Feb; 9():143-151. PubMed ID: 31008416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals.
    Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP
    Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation in Support of Internationally Harmonised OECD Test Guidelines for Assessing the Safety of Chemicals.
    Gourmelon A; Delrue N
    Adv Exp Med Biol; 2016; 856():9-32. PubMed ID: 27671718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probabilistic modelling of developmental neurotoxicity based on a simplified adverse outcome pathway network.
    Spînu N; Cronin MTD; Lao J; Bal-Price A; Campia I; Enoch SJ; Madden JC; Mora Lagares L; Novič M; Pamies D; Scholz S; Villeneuve DL; Worth AP
    Comput Toxicol; 2022 Feb; 21():100206. PubMed ID: 35211661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate.
    Fragki S; Piersma AH; Westerhout J; Kienhuis A; Kramer NI; Zeilmaker MJ
    Regul Toxicol Pharmacol; 2022 Dec; 136():105267. PubMed ID: 36367522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically based mathematical models of nanomaterials for regulatory toxicology: A review.
    Lamon L; Asturiol D; Vilchez A; Cabellos J; Damásio J; Janer G; Richarz A; Worth A
    Comput Toxicol; 2019 Feb; 9():133-142. PubMed ID: 31008415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a rat physiologically based kinetic model (PBK) for three organophosphate flame retardants (TDCIPP, TCIPP, TCEP).
    Deepika D; Sharma RP; Schuhmacher M; Kumar V
    Toxicol Lett; 2023 Jul; 383():128-140. PubMed ID: 37356742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Physiologically Based Kinetic modelling in addressing environmental chemical mixtures - A review.
    Desalegn A; Bopp S; Asturiol D; Lamon L; Worth A; Paini A
    Comput Toxicol; 2019 May; 10():158-168. PubMed ID: 31218267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies.
    Sakuratani Y; Horie M; Leinala E
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():20-28. PubMed ID: 29316278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of in vitro toxicity data and physiologically based kinetic modeling to predict dose-response curves for in vivo developmental toxicity of glycol ethers in rat and man.
    Louisse J; de Jong E; van de Sandt JJ; Blaauboer BJ; Woutersen RA; Piersma AH; Rietjens IM; Verwei M
    Toxicol Sci; 2010 Dec; 118(2):470-84. PubMed ID: 20833708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making in silico predictive models for toxicology FAIR.
    Cronin MTD; Belfield SJ; Briggs KA; Enoch SJ; Firman JW; Frericks M; Garrard C; Maccallum PH; Madden JC; Pastor M; Sanz F; Soininen I; Sousoni D
    Regul Toxicol Pharmacol; 2023 May; 140():105385. PubMed ID: 37037390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.